News

A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...
The investment comes as the FDA is pushing drug developers to phase out animal testing in some of the biologic treatments ...
The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods that it hopes will be more relevant to human physiology.
Feinberg Professor emerita Eva Redei’s research had two key components: vats of water and “depressed” rats. Redei found that ...
Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to ...
There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...
“Vivodyne is fundamentally changing how drugs move from the lab bench to human trials,” said Andrei Georgescu, Ph.D., CEO and ...
Navy Secretary John C. Phelan recently announced that the United States Navy would no longer engage in animal testing on dogs ...